Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemia

GL Uy, I Aldoss, MC Foster, PH Sayre, MJ Wieduwilt, AS Advani, JE Godwin, ML Arellano, KL Sweet, A Emadi, F Ravandi, HP Erba, M Byrne, L Michaelis, MS Topp, N Vey, F Ciceri, MG Carrabba, S Paolini, GA HulsMojca Jongen - Lavrencic, M Wermke, P Chevallier, E Gyan, C Récher, PJ Stiff, KM Pettit, Bob Löwenberg, SE Church, E Anderson, J Vadakekolathu, M Santaguida, MP Rettig, J Muth, T Curtis, E Fehr, K Guo, J Zhao, O Bakkacha, K Jacobs, K Tran, P Kaminker, M Kostova, E Bonvini, RB Walter, JK Davidson-Moncada, S Rutella, JF DiPersio

Research output: Contribution to journalArticleAcademicpeer-review

206 Citations (Scopus)
31 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemia'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry

Immunology and Microbiology

Biochemistry, Genetics and Molecular Biology